Clinical Trial Update: Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a cyclooxygenase-2 inhibitor in combination treatment for bipolar depression has completed, with results posted on 2024-04-0…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression

Snippet

Sponsor: Loyola University | Conditions: Bipolar Depression | Phase 4 | Status: COMPLETED | Results posted: 2024-04-09